4.21
price up icon1.12%   0.04
 
loading

Finanzdaten der Annexon Inc-Aktie (ANNX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
4.79%
28.57
30.01 34.78 37.69 41.24
Operating Income/Loss
4.79%
-28.57
-30.01 -34.78 -37.69 -41.24
Income/Loss From Continuing Operations Before Tax
110.46%
-25.18
240.58 -32.48 -35.19 -38.68
Income/Loss From Continuing Operations After Tax
110.46%
-25.18
240.58 -32.48 -35.19 -38.68
Net Income/Loss
9.73%
-25.18
-27.89 -32.48 -35.19 -38.68
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
14,201%
122.67
0.8578 75.34 75.23 73.86
Diluted Average Shares
14,201%
122.67
0.8578 75.34 75.23 73.86
Basic Earnings Per Share
40.00%
-0.21
-0.35 -0.43 -0.47 -0.52
Diluted Earnings Per Share
40.00%
-0.21
-0.35 -0.43 -0.47 -0.52
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$72.77
price down icon 0.98%
$38.60
price up icon 7.55%
$373.47
price up icon 1.36%
$23.88
price up icon 8.33%
biotechnology ONC
$221.75
price up icon 1.31%
$115.16
price down icon 1.79%
Kapitalisierung:     |  Volumen (24h):